The Bispecific Innate Cell Engager AFM28 Can Leverage AML Patient's NK Cells in Addition to Allogeneic NK Cells, Enabling Elimination of CD123+ Leukemic Stem and Progenitor Cells in AML and MDS
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Nanni Schmitt, Jana-Julia Siegler, Alexandra Beck, Lea Hoppe, Mohammed Abba, Alexander Streuer, Stefan Klein, Wolf-Karsten Hofmann, Christian Merz, Jens Pahl, Daniel Nowak
Institutions: Heidelberg University, Medizinische Fakultät Mannheim
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405039843